| Internet Electronic Journal of Molecular Design - IEJMD, ISSN 1538-6414, CODEN IEJMAT
 
| ABSTRACT - Internet Electron. J. Mol. Des. September 2004, Volume 3, Number 9, 528-543 |  | 
 Ligand-based Computation of HIV-1 Integrase Inhibition Strength
 within a Series of β-ketoamide Derivatives
Frederik F. D. Daeyaert, H. Maarten Vinkers, Marc R. de Jonge, Jan Heeres, Lucien M. H. Koymans, Paul J. Lewi, and Paul A. J. Janssen
 Internet Electron. J. Mol. Des. 2004, 3, 528-543
 
 |  Abstract:A continuous demand exists for novel bioactive molecules. When a
 lead structure has been discovered and looks promising for further
 development, series of analogues will be made. Normally, the
 synthesis of many compounds is required to improve on the
 activity, or to keep good activity while optimizing other properties
 of relevance. A computational model that accurately predicts the
 activity of derivatives before their synthesis is beneficial to the
 speed and cost of lead optimization. It can be advantageous when
 such a model does not require geometrical information on the
 target protein structure. A conformational analysis was performed
 on 201 ketoamide ester derivatives that inhibit HIV integrase. The
 derivatives were aligned to the lowest energy conformer of the
 most potent inhibitor with the SEAL method. Five CoMSIA fields
 were computed for each compound taking into account steric,
 polarizability, charge, H-bond acceptor, and H-bond donor
 properties. A model for integrase-inhibitor interaction was derived
 by PLS regression. The predictivity of the model was tested by
 scrambling the data, leave-n-out experiments and applying the
 model to a ketoamide acid series of integrase inhibitors. In order to
 elucidate the binding mode of the inhibitors, the model was
 mapped on a crystal structure of the integrase enzyme. The
 CoMSIA model derived from the 201 ketoamide ester derivatives
 has an R2 of 0.75. The resulting fields of the molecular properties
 required for strong inhibition can be qualitatively understood.
 Scrambling the data prohibited the derivation of a predictive
 model. The models derived from 100 derivatives when applied to
 the remaining 101 compounds, resulted in a prediction with an
 absolute deviation of 0.28 log10 unit/compound. The accuracy of
 prediction when the model was applied to 74 ketoamide acids was
 0.42 log10 unit/compound. Mapping the model onto the integrase
 enzyme did not lead to an obvious binding mode. The predictivity
 of our model allows for guiding the synthesis of novel analogues.
 Our approach holds its predictive value when applied to a different
 series of inhibitors. The geometry of integrase-inhibitor binding is
 not very well understood at the present time, which emphasizes the
 advantages of an approach that does not require this knowledge for
 the design of novel active compounds.
 
 
 |